Biopharmaceutical Industry Fellowship Program 2027-2029 1
Table of Contents 3
About Sanofi
4
Sanofi’s Worldwide Impact
5
AI at Sanofi
6
Belong. Beyond Boundaries.
7
About MCPHS
8
Letter from the Directors
9
Letter from the Chief Fellows
10
Fellowships 10 Portfolio 18 Immunology 21 Oncology 24 Neurology 26 Rare Diseases & Rare Blood Disorders
30
Application and Recruitment Process
31
Fellowship Alumni Spotlights 2
Who We Are At Sanofi, we are an R&D-driven, AI-powered biopharmaceutical company committed to improving people's lives and delivering compelling growth. We are united by a single, unwavering purpose: we chase the miracles of science to improve people's lives. Our shared ambition is bold and clear: turning the impossible into the possible for millions of people around the world.
A Legacy Of Innovation In the last half century, Sanofi has grown into one of the world's leading healthcare companies – a culmination of a diverse group of companies sharing a rich history in healthcare innovation dating back to the 19th century. Today, our footprint extends to 60 countries. Our deep understanding of the immune system and legacy in pursuing lifechanging science began more than 50 years ago when we delivered the world's first polio vaccine, a testament to the breakthrough thinking that continues to define us.
Our Values Delivering better outcomes for patients, healthcare systems, and society begins by creating an environment where every Sanofian can bring their best. Our mission is fueled by a culture of high performance and belonging, underpinned by four core values: Aim Higher, Act for Patients, Be Bold, and Lead Together.
Aim Higher
Act for Patients
Be Bold
Lead Together
Focus on what matters, set high standards and move with urgency, learning from setbacks as we go to achieve higher performance.
Never compromise on integrity, eliminate barriers and partner with others to go faster and further for patients.
Take thoughtful risks, seize opportunities and think beyond what’s possible to accelerate our science and drive compelling growth.
Build trust and collaborate openly on our shared goals, celebrate collective wins and foster a sense of belonging. 3
Making an Impact around the world
We’re present in over 60 countries.
~37
manufacturing sites ~15 R&D sites
6 million infants
Our medicines and vaccines are available in more than 160 countries.
500 million people
are immunized are vaccinated annually against respiratory with our vaccines syncytial virus (RSV). Every year we deliver over around the world.
2.1 billion healthcare solutions, helping make a difference in millions of lives all over the world.
Every year we deliver over 2.1 billion healthcare solutions, helping make a difference in millions of lives all over the world.
40 million patients could benefit from the medicines and vaccines currently in our pipeline.
Our Three Global Business Units
Specialty Care
General Medicines
Vaccines
Immunology Rare Diseases Rare Blood Disorders Neurology/Multiple Sclerosis Oncology
Autoimmune Type 1 Diabetes Type 2 Diabetes Cardiovascular Transplant Established Products
Influenza Polio, Pertussis, & Hib Meningitis Travel & Endemic RSV 4
We are an R&D driven, AI-powered biopharma company committed to improving people’s lives. We aim to shorten the time between discovery to therapy by pioneering an innovative pipeline and executing transformative launches at scale. We are building and deploying AI-based solutions across our value chain responsibly, empowering our people with innovative technology, from research and development to manufacturing and patient engagement, to accelerate delivery to patients.
We have begun to significantly reduce the time between the discovery of a new molecule and the moment it becomes a therapy available for patients, with the aim to get life changing medicines to patients faster than ever before.
“We are committed to providing the next-gen healthcare that patients and customers need. Through digital innovation, we will chase faster, search deeper and solve sooner.” Emmanuel Frenehard
Executive Vice President, Chief Digital Officer 5
Belong. Beyond Boundaries. Across every stage of our journey, from research and development to manufacturing and delivery, our inclusive culture shapes how we innovate, collaborate, and deliver breakthrough science that responds to patients’ realities.
Our 2030 Vision: Three Bold Leaps Patients
Miracles Begin With Us
People Great Minds Don’t Think Alike Places
Inclusion by Design
Patients see themselves in our clinical trials, feel understood in our communication and information, and can trust that we’re developing medicines and vaccines with their specific diverse need in mind. We're building fairness for all in healthcare.
People speak up without hesitation, collaborate freely with no artificial boundaries and silos, and know that their unique contributions is what drives our success. We're making inclusion everyone's business. Places are state of the art. From accessible offices, labs and sites to inclusive digital tools that are easy to use for all to medicines and vaccines that are designed, packaged and dispensed keeping in mind the needs of real-world diverse patients. We’re setting a new standard for accessibility. Roussel Connaught ‘
1911 1922
Clin Midy 1971
Robert & Carriere Wittman & 1901 Poulenc
1860
6
About MCPHS
The Massachusetts College of Pharmacy and Health Sciences (MCPHS) provides an academic environment to guide and support Fellows toward a successful career in the biopharmaceutical industry. As a private institution with a history of specialization in health sciences, MCPHS offers programs that embody scholarship, professional service, and community outreach. Through MCPHS, the Fellow will have the opportunity to gain teaching and research experience in an academic setting. MCPHS faculty and company Program Leaders mentor Fellows according to scholarly and professional interests throughout the 2-year program.
MCPHS Fellowship Team Amee Mistry, PharmD, RPh Biopharmaceutical Industry Fellowship Director and Professor of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences
Dr. Amee Mistry is Professor of Pharmacy Practice and has been with MCPHS since 2006. Dr. Mistry earned her PharmD at the Albany College of Pharmacy and completed a PGY1 Community Based Residency with Walgreens and MCPHS. In 2015, Dr. Mistry stepped into the role as Director of the MCPHS Biopharmaceutical Industry Fellowship Program. She works directly with leaders in the area to continue to foster growth and development of the post-graduate program, and to assist the fellows in attaining positions within the pharmaceutical industry.
Samantha Nganju, MBA
Biopharmaceutical Industry Fellowship Assistant Director, MCPHS
Alaina Buldini
Program Coordinator Biopharmaceutical Industry Fellowship, MCPHS
7
Letter from the Directors Dear Candidates, We would like to thank you for your interest in exploring our long-standing Sanofi/MCPHS Biopharmaceutical Industry Fellowship Program as you set out to write the next chapter in your professional career. We have had the privilege of seeing this program grow to be the largest, most well-known, and well-respected fellowship program in the industry. Our post-doctoral PharmD fellowship has a diverse offering of program opportunities across different functions and therapeutic areas, a seasoned panel of Program Directors and Preceptors, a strong network of over 50 Sanofi/MCPHS PharmD Fellows, and the support of an innovative company that is committed to its people and the patients we serve. Over the last two decades, we have had the honor of mentoring and learning from an incredibly talented group of professionals, and we look forward to continuing the tradition. On behalf of Sanofi, we wish you much success, whichever path you may choose. Sincerely, Co-Directors, Sanofi Specialty Care PharmD Fellowships
Jill Ilsley, PhD
Michael E. Tonn, PharmD, BCPS
Head of Medical Portfolio Strategy & Innovation NA Medical Specialty Care
Director of Field Medical Operations and Strategic Projects, Medical Value & Outcomes
8 9
Letter from the Chief Fellows Dear Candidates, Thank you for considering the Sanofi/MCPHS Biopharmaceutical Industry Fellowship program as the next step in your professional journey. While this new chapter can feel both exciting and overwhelming, we encourage you to take a moment to appreciate how far you have come and all that you have accomplished to reach this point. We know choosing the right fellowship is an important decision, and we're honored you're taking the time to learn about ours. Our program provides unique opportunities to contribute, learn, and grow within a biopharmaceutical organization committed to improving patients' lives. With approximately 20 fellowship positions, fellows benefit from a collaborative network of industry professionals working at the forefront of science and medicine. From building relationships with experienced leaders to participating in strategic initiatives and key business decisions, Sanofi/MCPHS fellows gain meaningful experiences that help prepare them to become future leaders in the industry.
As Chief Fellows, we have the privilege of representing a community of over 50 Sanofi/MCPHS fellows. We work closely with our Program Directors to advocate for the needs and interests of our cohort while fostering mentorship, collaboration, and networking opportunities. We are also incredibly fortunate to work alongside our three fellow-led committees that continue to achieve annual milestones for our program. To our current fellows, program leads, and preceptors: we thank you for your continued commitment to the fellowship and recruitment process. To our candidates and future leaders of the industry: we wish you all the best as you navigate the recruitment journey and find the right program for your career. Sincerely,
Lauryn Hill, PharmD
Paul Simental, PharmD
Co-Chief Fellow
Co-Chief Fellow
Nima Vahadji, Pharm D Co-Chief Fellow 2024-2025 Global/US Medical
9
PROGRAM LEAD Jill Ilsley, PhD
SPECIALTY CARE PORTFOLIO
Head of Medical Strategy & Innovation, Specialty Care NA
MEDICAL STRATEGY & INNOVATION Recruiting 2 Fellows Program and Goals: To develop expertise in medical strategy and innovation across Sanofi's Specialty Care portfolio (all therapeutic areas). Fellows will contribute to high-impact initiatives that accelerate clinical development and evidence generation, enhance healthcare professional and patient experiences, and advance AI-enabled capabilities shaping the future of Medical.
Core Focus
Preceptors
•
AI & Digital Innovation
•
Portfolio Strategy
•
Omnichannel Medical Engagement
First-Year Fellows
Risako Nettles, PharmD Melanie DeFusco, PharmD Stephanie Colucci, PharmD
Second-Year Fellow
Mia Atallah, PharmD
Paul Simental, PharmD
University of Connecticut
University of California, San Diego
Brayden Kraiss, PharmD University of Arizona
10
PROGRAM PROGRAM LEAD LEAD Michael E. Tonn, PharmD, BCPS
SPECIALTY CARE PORTFOLIO
Director of Field Medical Operations and Strategic Projects, Medical Value & Outcomes
MEDICAL VALUE & OUTCOMES Recruiting 1 Fellow Program and Goals: To develop advanced expertise in field medical interactions across the US healthcare landscape, including regional and national payers, Pharmacy Benefit Managers (PBMs), Accountable Care Organizations (ACOs)/Integrated Delivery Networks (IDNs), Medicare, Medicaid, and specialty pharmacies. Fellows will also gain dedicated exposure to the Health System Medical Value & Outcomes (MVO) role, engaging IDNs, health systems, and at-risk physician groups on disease pathway quality improvement and outcomes-based strategies. In addition to field medical training, fellows will develop competencies in real world evidence (RWE) generation and external research partnerships, clinical informatics and digital health strategy, and Medical Portfolio Strategy, including the development and compliant distribution of MVO tools and resources. Fellows will gain broad exposure to medical and commercial functions within Sanofi Specialty Care. Core Focus •
Medical Value & Outcomes roles (payer, health system)
•
Real World Evidence/External Research Partnerships
•
Medical Portfolio Strategy
•
Clinical Informatics
•
Medical Science Liaison roles
•
Access Strategy (commercial)
First-Year Fellow
Preceptors Erik Schindler, PharmD, BCPS Sara Alvarez, PharmD
Second-Year Fellow
Jenna Wildeman, PharmD
Eila Zhuang, PharmD
University of Washington
Northeastern University
11
PROGRAM LEAD Teri Michelini
SANOFI PORTFOLIO
Global Head, Scientific Publications & Data Sharing
MEDICAL STRATEGY & TRANSFORMATION NEW! Recruiting 1 Fellow Program and Goals: To develop practical, real-world industry experience in the core functions of Medical Strategy & Transformation team. The Fellow will have their choice of rotating within Scientific Publications and Data Sharing, Field Medical Excellence, Published Information, Scientific Communications Excellence, Medical Innovation and Program Management within the CMO office. The rotation-based structure allows fellows to develop broad, cross-functional expertise across the CMO while pursuing areas of personal and professional interest.
Core Focus •
Scientific Publications & Data Sharing
•
Global Field Medical Excellence
•
Published Information & Library Services
•
Cross-Functional CMO Program Management
•
Scientific Communications Excellence
Preceptors Teri Michelini, PharmD Christina Tankersley, PharmD
12
PROGRAM LEAD
SPECIALTY CARE PORTFOLIO
Puja Patel, PharmD, RPh
Pharmacovigilance (PV) Science Lead
PATIENT SAFETY & PHARMACOVIGILANCE Not Recruiting Program and Goals: To develop the ability to critically evaluate, interpret, synthesize, and present safety data in a clear and concise manner through written and verbal communication. Fellows will gain technical training and hands-on experiences with clinical development and marketed products to grow the necessary skill set and optimize patient safety as a Pharmacovigilance Scientist.
Core Focus •
Patient Safety & Pharmacovigilance (PV)
•
PV Regulations & Guidelines
•
Strategic Thinking
•
Project Management
•
Digital Innovation
First-Year Fellow
Preceptors Shaili Rathod, PharmD, RPh Iris Chen, PharmD
Second-Year Fellow
Hannah Venturini, PharmD
Paulina Nguyen, PharmD
Northeastern University
University of Southern California
13
PROGRAM LEAD Eric Racine, PharmD
SPECIALTY CARE PORTFOLIO
VP, Head of US Public Affairs & Patient Advocacy
PUBLIC AFFAIRS & PATIENT ADVOCACY Not Recruiting Program and Goals: To develop an understanding of US Public Affairs and Patient Advocacy (US PA&PA). Fellows will gain hands-on experience with advocacy group partnerships and professional societies while coordinating with external advocates and internal teams. Fellows will contribute to the improvement of patient health, acceleration of medical innovation, and access to medicines and vaccines by bridging insights and resources of the advocacy community and Sanofi.
Core Focus
Preceptor
•
Sanofi Specialty Care
•
Vaccines
•
General Medicines
Bernadette Wang, PharmD
First-Year Fellow
Francesca Sferella, PharmD
The University of Findlay
14
PROGRAM LEAD
SPECIALTY CARE PORTFOLIO
Ida Bixho, PharmD
Senior Medical Writer
CLINICAL DOCUMENTATION & MEDICAL WRITING Not Recruiting Program and Goals: To develop an understanding of clinical documentation and medical writing processes throughout the drug development life cycle. Fellows will gain training in writing and managing high quality clinical regulatory documents across different therapeutic areas while building skills in project management and regulatory health authority guideline processes.
Core Focus •
Regulatory Documentations
•
Project Management
•
Regulatory Health Authorities Guidelines
Preceptor Ida Bixho, PharmD
Second-Year Fellow
Daniella Salawu, PharmD, RPh, MSHI, MSBMS Regis University
15
PROGRAM LEAD Aurelie Kam
SPECIALTY CARE PORTFOLIO
Global Regulatory Capability & Learning Solution Lead
GLOBAL REGULATORY AFFAIRS: REGULATORY STRATEGY Recruiting 1 Fellow Program and Goals: To develop the necessary skills and tools to become a knowledgeable, confident, and strategic regulatory affairs professional. The Fellow will gain hands-on experience, developing a well-rounded understanding of the regulatory functions and drug development process from early stage to post -marketing, including how technology, especially artificial intelligence, can be leveraged to enhance our ways of working. Ultimately the fellow will become an integrated part of the GRA team through involvement in cross-functional projects with global colleagues.
Core Focus •
Global Regulatory Strategy
•
Health Authority Engagement
•
Submission Management & Dossier Production
•
Digital Regulatory Intelligence
•
Cross-Functional Collaboration
First-Year Fellow
Preceptors Priyal Soni, PharmD, RPh Amanda Miesal, PharmD, RPh
Second-Year Fellow
Brian Portela, PharmD
Linwei Jiang, PharmD
University of Connecticut
University of Florida
16
PROGRAM LEAD Aurelie Kam
SPECIALTY CARE PORTFOLIO
Global Regulatory Capability & Learning Solution Lead
GLOBAL REGULATORY AFFAIRS: CHEMISTRY, MANUFACTURING & CONTROLS (CMC) - BIOLOGICS
Not Recruiting
Program and Goals: To develop an understanding of the regulatory functions of Global Regulatory Affairs Chemistry, Manufacturing, Controls (CMC), focusing on Biologics. Fellows will gain knowledge of early stage to post-marketing development processes. Fellows will also assist the team in achieving and maintaining regulatory approvals to deliver safe, effective, and high-quality pharmaceutical products. Core Focus •
CMC Regulatory Strategy
•
Product Life Cycle Management
•
Regulatory Intelligence
•
Health Authority Interactions
•
Quality and Compliance Integration
Preceptor Maria O’Connell, MLIS, MS
First-Year Fellow
Yehun Lee, PharmD University at Buffalo
17
PROGRAM LEAD Chijioke Okafor, PharmD, MBA
IMMUNOLOGY
Head of Global Scientific Communications, Immunology
MEDICAL/SCIENTIFIC COMMUNICATIONS (PIPELINE) Recruiting 1 Fellow Program and Goals: To develop a comprehensive understanding of Scientific Communications, a key function within Global Medical teams. Fellows will gain experience in medical communications, education, and publications while contributing to advancing patient care and global product strategies. Rotational opportunities may include medical director, medical science liaison (MSL), health economics value assessments (HEVA), medical value and outcomes (MVO), and additional options based on fellow interest.
Core Focus •
Publications Strategy
•
Medical Communications
•
Congress Strategy
•
Omnichannel Digital Strategy
•
Medical Education
•
Medical Affairs
Preceptors Hannah Kim, PharmD Priyanka Trivedi, PharmD Morenike Ogunnaike, PharmD Dwipi Patel, PharmD
Second-Year Fellow
First-Year Fellow
Gabrielle Blanco, PharmD, MBA
Krishna Padodara, PharmD
University of Rhode Island
Temple University
18
PROGRAM LEAD Yaswant Dayaram, PhD, CMPP
IMMUNOLOGY
Global Head, Scientific Communications, Publications & Medical Education, Immunology
GLOBAL MEDICAL/SCIENTIFIC COMMUNICATIONS Recruiting 1 Fellow Program and Goals: The Fellow will serve as a key member of the Scientific Communications team within Alliance immunology, collaborating with global medical teams to develop and disseminate impactful scientific educational content within the immunology therapeutic area. This is a highly strategic role that drives meaningful HCP education and engagement while offering comprehensive exposure to the tactical aspects of scientific communications. The Fellow will gain hands-on experience across medical communications, including medical education, publications, omnichannel strategy and execution, and congress strategy, all while contributing to initiatives that advance patient care and align with global organizational objectives. Throughout the program, the Fellow has opportunities to rotate through various medical functions to enrich and broaden their experience. Core Focus •
Medical Communications
•
Strategic Publication Planning
•
Medical Education
•
Omnichannel Digital Strategy
•
Congress Strategy
First-Year Fellows
Preceptors Colin Mitchell, PhD Waverly Yang, PharmD Yuan Wang, PharmD, CMPP
Second-Year Fellow
Chloe Flibbert, PharmD
Hannah Summers, PharmD, RPh
Massachusetts College of Pharmacy and Health Sciences
University of North Carolina at Chapel Hill
Phuong Do, PharmD The University of Texas at Austin
19
PROGRAM LEAD Angharad Ratliff, PharmD,
IMMUNOLOGY
Field Scientific Associate Director, NA Medical Immunology
MEDICAL/MEDICAL SCIENCE LIAISON (MSL) Recruiting 3 Fellows Program and Goals: To develop a comprehensive understanding of Medical roles within the pharmaceutical industry, particularly focusing on the Medical Science Liaison (MSL) and Medical Affairs functions. Fellows will gain expertise on field medical activities and complete MSL certification, while contributing to the medical strategy and collaborating cross-functionally to generate medical evidence and disseminate clinical and scientific data and education. Core Focus
Preceptors
•
US Medical Science Liaison Team
•
External Stakeholder Engagement
•
Medical Education
•
Congress Planning & Coverage
•
Cross-Functional Collaboration
Danielle Pariseau, PharmD Nikki Lewis, PharmD
Second-Year Fellows
First-Year Fellows
Katya Kornievskaia, PharmD
Lauryn Hill, PharmD
University of Michigan
Florida A&M University
Sara Alani, PharmD
Tim Brown, PharmD
University of Rhode Island
University of Arizona
Gianna Marino, PharmD
Maherah Shaikh, PharmD
University of Illinois Chicago
Western New England University
20
PROGRAM LEAD Jueli Li, PharmD
ONCOLOGY
Associate Director, Global Scientific Communications & Publications Lead Radioligand Therapy
MEDICAL STRATEGY & OPERATIONS
Not Recruiting Program and Goals: To develop a comprehensive understanding of how Global Medical Affairs drives strategy and execution across the product lifecycle. Fellows will gain hands-on experience in medical plan development, congress strategy, advisory board design, and evidence dissemination. This program emphasizes cross-functional collaboration, insight integration, and operational excellence, preparing fellows to contribute to advancing global medical priorities and supporting impactful product strategies.
Core Focus •
Strategic Medical Objective & Plan Development
•
Publication Planning & Execution
•
Congress Symposium/Booth Strategy/Training
•
Advisory Board Planning & Insight Generation
•
Medical Communication & Cross-Functional Collaboration
Preceptors Jueli Li, PharmD Lamar Blackwell, PhD
Second-Year Fellow
Shirley Nguyen, PharmD University of Illinois Chicago
21
PROGRAM LEAD Ryan Carstens, PhD
ONCOLOGY
Director of Field Medical Operations, Strategic Projects
MEDICAL/MEDICAL SCIENCE LIAISON (MSL) Recruiting 1 Fellow Program and Goals: To develop a comprehensive understanding of Medical roles within the pharmaceutical industry, particularly focusing on the Medical Science Liaison (MSL) and Medical Affairs functions. Fellows will gain expertise on field medical activities and complete MSL certification, while contributing to the medical strategy and collaborating cross-functionally to generate medical evidence and disseminate clinical and scientific data and education.
Core Focus
Preceptor
•
Strategic Plan Development
•
Medical Education
•
External Stakeholder Engagement
•
Field Based Medical
•
Competitive Intelligence
First-Year Fellow
Ryan Carstens, PhD
Second-Year Fellows
Edward Tupper, PharmD
Karnav Dalal, PharmD
University of Saint Joseph
Rutgers University
Katie Martinez, PharmD University of Washington
11 22
PROGRAM LEAD Joaquin Garcia-Lopez
ONCOLOGY
Senior Director of Operations, Global Oncology
COMMERCIAL STRATEGY Recruiting 2 Fellows Program and Goals: To develop a deep understanding of franchise marketing strategies and nurture PharmD talent for leadership roles. Fellows will gain insights into competitive dynamics, customer needs, product positioning, and marketing content, preparing them for careers in pharmaceutical product management, commercialization, and market development. Core Focus
Preceptors
•
Global Marketing
•
Global Franchise Strategy
•
New Product Planning & Operations
•
US Marketing
•
US Market Access
First-Year Fellow
Hannah Menard, MBA Anju Bhalla
Second-Year Fellow
Misk Al Qaderi, PharmD
Ivan Fernandez, PharmD
University of Arizona
St. John's University
11 23
PROGRAM LEAD Svend Geertsen
NEUROLOGY
Head of Global Scientific Communications, Neurology
SCIENTIFIC/MEDICAL COMMUNICATIONS Recruiting 2 Fellows Program and Goals: To develop a comprehensive understanding of Scientific Communications, a key function within Global Medical teams. Fellows will gain experience in medical communications, education, and publications while contributing to advancing patient care and global product strategies. Rotational opportunities may include medical director, medical science liaison (MSL), health economics value assessments (HEVA), medical value and outcomes (MVO), and additional options based on fellow interest. Core Focus
Preceptors
•
Medical Communications
•
Strategic Publication Planning
•
Medical Director Collaboration
•
Medical Strategy
•
Congress Planning & Execution
•
Medical Science Liaison Certification
First-Year Fellows
Anthony Hage, PharmD Alexandra Ilsley, PharmD
Elena Tormo, PharmD, RPh
Second-Year Fellows
Sihyun Kim, PharmD
Samuel Oliver, PharmD
University of Michigan
The University of Findlay
Chinmayi Joshi, PharmD Rutgers University
Jessie Hundel, PharmD Massachusetts College of Pharmacy and Health Sciences
11 24
PROGRAM LEAD Chirayu Parikh, PharmD
NEUROLOGY
Field Medical Director, Next Gen Respiratory and GI
MEDICAL/MEDICAL SCIENCE LIAISON (MSL) Recruiting 2 Fellows Program and Goals: To develop a comprehensive understanding of Medical roles within the pharmaceutical industry, particularly focusing on the Medical Science Liaison (MSL) and Medical Affairs functions. Fellows will gain expertise on field medical activities and complete MSL certification, while contributing to the medical strategy and collaborating cross-functionally to generate medical evidence and disseminate clinical and scientific data and education. Core Focus
Preceptors
•
Headquarters US Medical Directors
•
Scientific Communications & Engagements
•
Advisory Board Planning
•
Congress Planning/Symposium/Booth Strategy
•
Brand Plan Strategy
•
Intensive MSL Mentorship
•
KOL Engagements
First-Year Fellows
Dean Bowen, PharmD Avani Malladi, PharmD Rebecca Zhou, PharmD Kelly Covert, PharmD Candy Lu, PharmD, MBA
Second-Year Fellow
Matthew Hohenwalter, PharmD, MBA Washington State University
Paul Rademacher, PharmD University of Wisconsin-Madison
Gabrielle Gorwitz, PharmD University of Florida
11 25
PROGRAM LEAD
RARE DISEASES & RARE BLOOD DISORDERS
Sandra Casiano
Head of Global Scientific Communications, Rare Diseases
SCIENTIFIC/MEDICAL COMMUNICATIONS
Recruiting 3 Fellows
Program and Goals: To develop a comprehensive understanding of Scientific Communications, a key function within Global Medical teams. Fellows will gain experience in medical communications, education, and publications while contributing to advancing patient care and global product strategies. This fellowship is primarily focused on Scientific Communications, with project-based work and selective shadowing opportunities available in areas including Health Economics & Value Assessment (HEVA), Medical Affairs, and Medical Science Liaisons (MSLs), depending on fellow interest and availability.
Core Focus •
Medical Communications
•
Publications
•
Medical Education
•
Medical Digital Initiatives
•
Strategic Planning & Operations
•
Congress & Training
Preceptors Samira Mawla, PharmD Marta Borchiellini, PharmD, PhD Monique Bidell, PharmD Christine Istanboulian, PharmD
Second-Year Fellows
First-Year Fellows
Michelle Tan, PharmD
Christina Sabu, PharmD
Rutgers University
University of North Carolina at Chapel Hill
Vy Tran, PharmD
Olivia Raroque, PharmD
Virginia Commonwealth University
University of Southern California
11 26
PROGRAM LEAD
RARE DISEASES & RARE BLOOD DISORDERS
Angelo Walton, PharmD, RPh
Medical Strategy Account Director, Rare Diseases
MEDICAL/MEDICAL SCIENCE LIAISON (MSL): RARE DISEASES
Recruiting 1 Fellow
Program and Goals: To develop a comprehensive understanding of Medical roles within the pharmaceutical industry, particularly focusing on the Medical Science Liaison (MSL) and Medical Affairs functions. Fellows will gain expertise on field medical activities and complete MSL certification, while contributing to the medical strategy and collaborating cross-functionally to generate medical evidence and disseminate clinical and scientific data and education.
Core Focus •
Medical Strategy Development
•
External stakeholder and Health Systems Engagement
•
Field Based Medical Led Education
•
Congress Planning and Coverage
•
Cross-functional Collaboration
Preceptors Angelo Walton, PharmD Jennifer Matthews, M.S. Jonathan Tang, PharmD
Second-Year Fellow
First-Year Fellow
Erica Jermain, PharmD
Regan Dennis, PharmD
The University of Texas at Austin
University of South Carolina
11 27
PROGRAM LEAD
RARE DISEASES & RARE BLOOD DISORDERS
Dina Issa, PharmD Senior Medical Director, Hemophilia
MEDICAL/MEDICAL SCIENCE LIAISON (MSL): RARE BLOOD DISORDERS
Recruiting 1 Fellow
Program and Goals: To develop a comprehensive understanding of Medical roles within the pharmaceutical industry, particularly focusing on the Medical Science Liaison (MSL) and Medical Affairs functions. Fellows will gain expertise on field medical activities and complete MSL certification, while contributing to the medical strategy and collaborating cross-functionally to generate medical evidence and disseminate clinical and scientific data and education.
Core Focus •
Clinical Study Unit Operations
•
Medical Science Liaison Certification & Field Experience
•
Medical Affairs Strategy & Leadership
•
Congress Planning & Execution
Preceptor Dina Issa, PharmD
Second-Year Fellow
First-Year Fellow
David Fiedorczyk, PharmD, MBA
Sebastien Chenin, PharmD
University of Rhode Island
Northeastern University
11 28
PROGRAM LEAD
RARE DISEASES & RARE BLOOD DISORDERS
Stephanie Lally, MBA
Head of Franchise Operations, Global Rare Diseases
COMMERCIAL STRATEGY & MARKETING
Recruiting 2 Fellows
Program and Goals: To develop a deep understanding of Franchise marketing strategies and nurture PharmD talent for leadership roles. Fellows will gain insights into competitive dynamics, customer needs, product positioning, and marketing content, preparing them for careers in pharmaceutical product management, commercialization, and market development.
Core Focus •
Strategic Marketing & Brand Planning
•
Data-Driven Decision Making
•
Cross-functional Leadership
•
Franchise Marketing Operations
•
Content Development & Agency Management
First-Year Fellows
Preceptors Kara Bogart McManus, MS Lane Wilson, BSBA Laura Brill, BS
Second-Year Fellow
Mahi Ojha, PharmD
Amanda Cuello, PharmD
Saint Joseph’s University
University of Florida
Tiffany Chao, PharmD Rutgers University
11 29
Application and Recruitment Process Eligibility The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. •
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
•
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
•
All candidates must have authorization to work in the United States throughout the duration of the one- or two-year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).
Application Procedure The MCPHS application portal (SMApply) will open up Monday, October 5, 2026. Applicants must upload the following application materials to the online portal, (https://mcphs.smapply.io/) by Monday, November 2, 2026:
•
Letter of intent (addressed to the company specific program director/lead; found in each company brochure)
•
Curriculum vitae
•
Unofficial college transcript
•
Contact information for three references. References will receive an electronic recommendation form to complete separately.
ASHP Midyear & Onsite Interviews The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in Orlando, FL. Attendance is strongly encouraged but not required. Please refer to the ASHP & PPS website for registration details. Top candidates may be invited for interviews at the sponsoring company’s location.
AIFA First Offer Date
Three recommendation evaluation forms must be submitted no later than Friday, November 20, 2026, via the online portal. This is NOT a letter of recommendation but an online form that the recommender will receive for completion from SMApply.
The choice of a Post-Doctoral Fellowship is an important decision. MCPHS, in conjunction with the Alliance of Industry Fellowship Associates (AIFA), has aligned to extend offers for Fellowships no earlier than Friday, December 11, 2026. We believe this is a positive reflection of the cultures our Programs offer, and that culture is a critical consideration in choice of Fellowship.
Application Review and Interview Timeline
We hope that other academic and non-academic Fellowship Programs will NOT pressure candidates to accept offers prior to this aligned offer date.
Following a review of submitted applications, pre- screens and preliminary interviews will begin in October. Additional interviews, including final rounds will take place in December during ASHP. Candidates will be notified if selected for an interview. The process is rigorous and competitive; therefore, candidates should submit their applications well in advance of posted deadlines as priority will be given to those who apply early.
Onboarding Final candidates will be required to go through additional screening / onboarding as required by MCPHS.
30
Fellowship Alumni Spotlight Victoria Lee Class of 2026 Medical Science Li aison, Dermatology
Shannon Gallo
Aabha Daryapurkar Class of 2026 Pharmacovigil ance Sci entist, Immunology & Infl ammation
Anthony Chan
Class of 2026 Regulatory St rat egist, Oncology
Class of 2026 Regulatory Strategist, Immunol ogy & Inflammati on
Celia Parisi
Sumoda Achar
Class of 2026 Medical Strategic Account Associ ate Director, Rare Diseases
Class of 2026 Senior Manager, US Portfolio Marketing, Rare Blood Disorders
Elena Tormo
Kimberly Forbes
Class of 2026 Associat e Director, Global Scientific Communicat ion Lead, Neurology
Class of 2026 Associat e Director Field Learning and Dev elopment - Al lergy, ENT
Morenike Ogunnaike
Nima Vahadji
Lucas Zhou Class of 2026 Associat e Director, Fiel d Learning & Dev elopment
Richa Patel Class of 2026 GRA CMC Lead, Biologic Products
Sloan Smith Class of 2026 Medical Science Li aison, Hematologic Oncology
Andrew Capozzi Class of 2025 Pharmacovigil ance Scientist
Karli Kaye
Class of 2025 Global Scientific Communications Lead, Rheumatology, Immunology
Class of 2025 Medical Insi ghts and Operations Lead, Oncology
Class of 2025 Global Scientific Communications Lead - Immunology (Dermat ology)
Shani Patel
Josef Wills
Rebecca Zhou
Class of 2024 Regional Medi cal Account Di rector, Health Sy stem Medical Value & O ut comes
Class of 2024 Medical Science Li aison, Neuromuscular
Saadi Aalem
Madison Burns
Class of 2024 Medical Science Li aison, Neuromuscular
Cassandra Goodman
Class of 2024 Pharmacovigil ance Scientist
Class of 2024 Regulatory Strategist, Immunology
Class of 2024 Head of Operations, US and Global, Specialty Care Corporate Affai rs
Subanky Sivagnanalingam
Katia Fangmeyer
Jake Kirkpatrick
Class of 2024 Global Sci entific Communications Lead, Dermatology Immunology
Class of 2024 Global Associ ate Medical Director, Dermatology
Waverly Yang
Melissa Horenstein
Class of 2023 Sci entific Direct or, Global Sci entific Communicat ions - Respiratory
Saerom Hwang
Class of 2023 Associat e Director, Global Publicat ions Lead, Rhinology
Vishal Shahidadpury
Class of 2024 Medical Science Li aison, Pulmonary
Abigail Nesbeth Class of 2023 Associat e Medical Director Stakeholder Engagement, Dermatology/Rheumat ology
Rong (BeiBei) Ding
Class of 2023 Senior Medical Writer
Class of 2023 Medical Sci ence Liaison, Rheumat ology
Class of 2023 Director, Global Market Access and Prici ng, Neurology
Jonathan Tang
David Farber
Hannah Kim
Class of 2023 Medical Strategic Account Associat e Director
Class of 2023 US Associate Medi cal Director, Rare Blood Disorders
Class of 2022 Associat e Director, Global Scientific Communicat ions, Immunology 31
Fellowship Alumni Spotlight Madison Sierakowski
Kristy Fang
Class of 2022 Medical Science Li aison - Dermatology
Class of 2022 Medical St rat egic Account Director, Rare Di sease
Patrice Gabriel
Reema Patel
Class of 2022 Medical Associate Director, Rare Hematology
Class of 2022 Medical Science Li aison, Multi pl e Scl erosis
Stephen Pitarys
Victoria Flood
Class of 2022 GRA-CMC Biologics Lead
Class of 2022 Regulatory Strategist, Oncology
Dean Bowen
Risa (Risako) Nettles
Class of 2022 Senior Medical Sci ence Liaison, Neurology
Class of 2021 Medical Innovati on Accelerati on Lead, North America, Specialty Care
Avani Malladi
Bella Pangaribuan Coffin
Class of 2021 Medical Science Li aison, Neuromuscular
Christina Ha
Class of 2018 Fi eld Medical Director, Next Gen NE
Mason Benjamin Class of 2022 Health V alue Translation Lead
Gina Boris Class of 2021 Benefit-Risk Expert
Ida Bixho
Belle Estee Dante
Michelle Li
Jennifer Alfano
Class of 2022 Pharmacovigil ance Scientist
Stephanie Colucci
Priyal Soni
Class of 2020 Associat e Director Global Scientific Communicat ions Lead, Neurology
Shaili Rathod
Class of 2021 Associat e Director, Pri nci pal Medical Writ er
Class of 2021 Portfoli o Operati ons and Communications Lead, Gl obal Medical , Specialty Care
Anthony Hage
Class of 2022 Director, B2B Strategy & Sol ut ions, Rare Di sease
Class of 2021 Head, Account Engagement Marketing, US Rare Di sease
Class of 2021 GTMC Medical Omnichannel Capabiliti es Lead
Class of 2020 Regulatory St rat egist , Neurology
Lane Anson
Class of 2021 Pat ient Recrui tment and Retent ion Lead
Kristin Wells
Class of 2020 Director, Access Strategy AD
Class of 2020 Director, National Accounts, Medical Value & Outcomes
Parth Savalia
Rosemary Richardson
Class of 2019 Associat e Director, Peer to Peer Marketing
Class of 2019 Medical Direct or, US Hemat ologyOncology
Nathan Thibault
Jennifer Nitko
Class of 2017 Global Medical Lead, AATD, Rare Medical Launch & Pipeline Portfolio
Class of 2016 Global Regulatory Lead, Established Products Franchise
Jessica Bannan Class of 2015 Director, US Advertising and Promotion, Global Regulatory Affairs
32
Fellowship Testimonials Victoria Lee
Class of 2026 – Medical Science Liaison, Dermatology "My MCPHS/Sanofi fellowship with the US Medical Affairs/MSL: Immunology (Dermatology) team provided exceptional opportunities for professional and personal growth. Through hands-on field experience, national conference engagement, cross-functional collaboration, and the opportunity to bring innovative ideas to life, I made meaningful contributions while expanding my industry expertise. As a fellow who transitioned into a full-time role on the team, I look forward to providing the same mentorship and inspiration to future fellows."
Shannon Gallo
Class of 2026 – Regulatory Strategist, Oncology “My time as a Global Regulatory Affairs Fellow at Sanofi provided me with extensive hands-on experience and visibility across the organization. I worked with teams who were genuinely invested in my development and built a strong network of individuals who continue to support me today. The fellowship program struck the perfect balance between mentorship and autonomy, exposing me to the breadth of regulatory work and preparing me well for my current role as a Regulatory Strategist."
Aabha Daryapurkar
Class of 2026 – Pharmacovigilance Scientist, Specialty Care - Immunology & Inflammation “My fellowship with MCPHS and Sanofi was truly transformative, offering enriching mentorship, hands-on experience, and impactful collaborations that prepared me well for my transition into a full-time role. Serving as the Chief Fellow of my cohort enhanced my leadership skills and reinforced the power of building cohesive teams. The personalized growth and supportive culture I experienced gave me both the confidence and foundation to make a meaningful impact from day one.”
Anthony Chan
Class of 2026 – Regulatory Strategist, Immunology & Inflammation “The Global Regulatory Affairs fellowship at Sanofi provided a customized developmental experience that accelerated my transition into a Regulatory Strategist role. Working with a team committed to my professional growth, I gained diverse hands-on experience while building a network of accomplished peers whose insights continue to inform my regulatory strategy and career decisions.” 23 33
We chase the miracles of science to improve people’s lives.
©2026 Sanofi. All rights reserved.
MAT-US-2609166-v2.0-09/2026
24 34